SEBON Adds 7.06 Lakh IPO Shares of Accord Pharmaceuticals in its Pipeline

The Securities Board of Nepal (SEBON) has added the Initial Public Offering (IPO) of Accord Pharmaceuticals Limited.

The company is seeking to issue 706,909 unit shares worth Rs. 7.06 crores at par value of Rs 100 per share. The application was submitted to SEBON on Poush 04, 2079.

Global IME Capital has been appointed as the issue manager for the IPO issuance.

Accord Pharmaceuticals Limited is a new entrant in the Nepalese pharmaceutical industry established as a private limited company. The company was registered in 2013 with no operational assets. The company was later converted into a public limited company in July 2021. The company has established its manufacturing unit in Kathmandu and is in the business of pharmaceutical production using active pharmaceuticals ingredients (API) imported from India and China.